Aprea Therapeutics, Inc. (APRE)

NASDAQ: APRE · Real-Time Price · USD

1.060

0.00 (0.00%)

At close: Dec 5, 2025, 4:00 PM EST

1.040

-0.020 (-1.88%)

After-hours: Dec 5, 2025, 6:19 PM EST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Novel Synthetic Lethality-based Cancer Therapeutics	1.50M	Log In
Novel Synthetic Lethality-based Cancer Therapeutics Growth	157.63%	Log In

Revenue by Geography

Fiscal year is January - December.